Ketamine One Appoints Two New Members to Its Medical Advisory Board
January 05, 2022 03:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
Ketamine One Announces 2021 AGSM Results
December 20, 2021 11:11 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), a company focused on consolidating...
Ketamine One Reports Strong 1Q22 Financial Results
December 16, 2021 03:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 16, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
Ketamine One Announces Lifting of Management Cease Trade Order
December 15, 2021 07:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 15, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
December 14, 2021 17:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 14, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year
December 13, 2021 17:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 13, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
KetamineOne Adds Seattle Location to US Clinical Network
December 08, 2021 03:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), a company focused on consolidating...
KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA
December 02, 2021 17:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), a company focused on consolidating...
Ketamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on Depression and PTSD
December 02, 2021 08:30 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: 6FC), a company focused on consolidating...
Ketamine One Provides Second Update on Management Cease Trade Order
November 29, 2021 07:00 ET
|
KetamineOne Capital Limited
VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: 6FC), a company focused on consolidating...